ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)
University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA- approved clinical trial for Post-Traumatic Stress Disorder (PTSD)
ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD).
University of Nebraska Medical Center and ANANDA Scientific announce FDA approval of the IND for a Clinical Trial exploring Treatment for Post-Traumatic Stress Discorder (PTSD)
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to Be Clinically Evaluated for Opioid Use Disorder – Mt Sinai Hospital
ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post- Traumatic Stress Disorder (PTSD)
ANANDA Scientific and NYU Grossman School of Medicine Announce Second Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for Evaluating Its Effect on Opioid Sparing in Participants with Chronic Radiculopathic Pain Syndromes
ANANDA Scientific and NYU Grossman School of Medicine Announce Clinical Trial Utilizing Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
ANANDA Scientific and NYU Grossman School of Medicine Announce Clinical Trial Utilizing Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
ANANDA Scientific appoints Sohail Zaidi as its new president.
John Suh Joins ANANDA Scientific’s Board of Directors as Executive Director.
ANANDA Scientific Initiates Human Clinical Trial for Liquid Structure™ CBD Formulation.